Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

被引:295
作者
Letvin, NL
Mascola, JR
Sun, Y
Gorgone, DA
Buzby, AP
Xu, L
Yang, ZY
Chakrabarti, B
Rao, SS
Schmitz, JE
Montefiori, DC
Barker, BR
Bookstein, FL
Nabel, GJ
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
[3] Duke Univ, Med Ctr, Durham, NC 27710 USA
[4] Univ Washington, Dept Stat, Seattle, WA 98195 USA
[5] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
[6] Univ Vienna, Dept Anthropol, A-1010 Vienna, Austria
关键词
D O I
10.1126/science.1124226
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vaccine-induced cellular immunity controls virus replication in simian immunodeficiency virus (SIV) - infected monkeys only transiently, leading to the question of whether such vaccines for AIDS will be effective. We immunized monkeys with plasmid DNA and replication-defective adenoviral vectors encoding SIV proteins and then challenged them with pathogenic SIV. Although these monkeys demonstrated a reduction in viremia restricted to the early phase of SIV infection, they showed a prolonged survival. This survival was associated with preserved central memory CD4(+) T lymphocytes and could be predicted by the magnitude of the vaccine-induced cellular immune response. These immune correlates of vaccine efficacy should guide the evaluation of AIDS vaccines in humans.
引用
收藏
页码:1530 / 1533
页数:4
相关论文
共 22 条
  • [1] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
    Amara, RR
    Villinger, F
    Altman, JD
    Lydy, SL
    O'Neil, SP
    Staprans, SI
    Montefiori, DC
    Xu, Y
    Herndon, JG
    Wyatt, LS
    Candido, MA
    Kozyr, NL
    Earl, PL
    Smith, JM
    Ma, HL
    Grimm, BD
    Hulsey, ML
    Miller, J
    McClure, HM
    McNicholl, JM
    Moss, B
    Robinson, HL
    [J]. SCIENCE, 2001, 292 (5514) : 69 - 74
  • [2] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
    Barouch, DH
    Santra, S
    Schmitz, JE
    Kuroda, MJ
    Fu, TM
    Wagner, W
    Bilska, M
    Craiu, A
    Zheng, XX
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Nickerson, CE
    Trigona, WL
    Punt, K
    Freed, DC
    Guan, LM
    Dubey, S
    Casimiro, D
    Simon, A
    Davies, ME
    Chastain, M
    Strom, TB
    Gelman, RS
    Montefiori, DC
    Lewis, MG
    Emini, EA
    Shiver, JW
    Letvin, NL
    [J]. SCIENCE, 2000, 290 (5491) : 486 - 492
  • [3] Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
    Casimiro, DR
    Wang, FB
    Schleif, WA
    Liang, XP
    Zhang, ZQ
    Tobery, TW
    Davies, ME
    McDermott, AB
    O'Connor, DH
    Fridman, A
    Bagchi, A
    Tussey, LG
    Bett, AJ
    Finnefrock, AC
    Fu, TM
    Tang, AM
    Wilson, KA
    Chen, MC
    Perry, HC
    Heidecker, GJ
    Freed, DC
    Carella, A
    Punt, KS
    Sykes, KJ
    Huang, LY
    Ausensi, VI
    Bachinsky, M
    Sadasivan-Nair, U
    Watkins, DI
    Emini, EA
    Shiver, JW
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (24) : 15547 - 15555
  • [4] HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1 - Infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccine
    Gilbert, PB
    Ackers, ML
    Berman, PW
    Francis, DP
    Popovic, V
    Hu, DJ
    Heyward, WL
    Sinangil, F
    Shepherd, BE
    Gurwith, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (06) : 974 - 983
  • [5] CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3
    Hulgan, T
    Raffanti, S
    Kheshti, A
    Blackwell, RB
    Rebeiro, PF
    Barkanic, G
    Ritz, B
    Sterling, TR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (06) : 950 - 957
  • [6] Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys
    Letvin, NL
    Huang, Y
    Chakrabarti, BK
    Xu, L
    Seaman, MS
    Beaudry, K
    Korioth-Schmitz, B
    Yu, F
    Rohne, D
    Martin, KL
    Miura, A
    Kong, WP
    Yang, ZY
    Gelman, RS
    Golubeva, OG
    Montefiori, DC
    Mascola, JR
    Nabel, GJ
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (14) : 7490 - 7497
  • [7] Proguss toward an HIV vaccine
    Letvin, NL
    [J]. ANNUAL REVIEW OF MEDICINE, 2005, 56 : 213 - 223
  • [8] The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection
    Lifson, JD
    Nowak, MA
    Goldstein, S
    Rossio, JL
    Kinter, A
    Vasquez, G
    Wiltrout, TA
    Brown, C
    Schneider, D
    Wahl, L
    Lloyd, AL
    Williams, J
    Elkins, WR
    Fauci, AS
    Hirsch, VM
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (12) : 9508 - 9514
  • [9] Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
    Mattapallil, JJ
    Douek, DC
    Hill, B
    Nishimura, Y
    Martin, M
    Roederer, M
    [J]. NATURE, 2005, 434 (7037) : 1093 - 1097
  • [10] Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
    Mellors, JW
    Rinaldo, CR
    Gupta, P
    White, RM
    Todd, JA
    Kingsley, LA
    [J]. SCIENCE, 1996, 272 (5265) : 1167 - 1170